Analyst Ratings for HCA Healthcare Inc (HCA)
HCA Rating Summary
HCA Price Target Summary
- Highest: $635.00 (UBS)
- Lowest: $423.00 (Baird)
- Average: $531.74
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$531.74 (-0.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$531.74 (-0.2%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/15/2025 | Morgan Stanley | Craig Hettenbach | Downgrade | Underweight (Equalweight) |
425.00 (N/A) |
482.35 (532.81) |
10.46% | Details |
| 10/14/2025 | Goldman Sachs » Updated 1/28/2026 |
Scott Fidel | New Coverage | Buy (N/A) |
558.00 (N/A) |
415.14 (532.81) |
28.34% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
